The negative effect of concomitant medications on immunotherapy in non-small cell lung cancer: An umbrella review

CONCLUSIONS: The concurrent usage of PPIs or steroids adversely affects the survival of patients with NSCLC receiving immunotherapy. Future investigations are required to ascertain whether these adverse effects are primarily attributed to the comorbidities or the concurrent medications.PMID:37722262 | DOI:10.1016/j.intimp.2023.110919
Source: International Immunopharmacology - Category: Allergy & Immunology Authors: Source Type: research